Serum Bone Turnover Markers (PINP and ICTP) for the Early Detection of Bone Metastases in Patients With Prostate Cancer: A Longitudinal Approach
To access this article, please choose from the options below
Nothing to disclose.Study received hospital ethical board approval.For another article on a related topic see page 1086.Editor’s Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 1128 and 1129.
PII: S0022-5347(07)01238-4
doi:10.1016/j.juro.2007.05.029
© 2007 American Urological Association. Published by Elsevier Inc. All rights reserved.
Refers to article:
- Endogenous Bone Morphogenetic Protein-7 Controls the Motility of Prostate Cancer Cells Through Regulation of Bone Morphogenetic Protein Antagonists , 18 July 2007

